Infectious Diseases News and Research

RSS

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

The University of Louisville has received funding from the U.S. Department of Defense (DoD) to develop a nasal spray to prevent serious viral respiratory infections such as COVID-19 using Q-Griffithsin, a drug compound developed and co-owned by UofL.

9 Dec 2020

Neutrophils may play a key role in COVID-19-related thrombosis

A team of researchers in Italy have published a study suggesting that rather than platelets, neutrophils could be playing the lead role in thrombotic complications associated with COVID-19.

9 Dec 2020

WHO highlights leading causes of mortality and morbidity worldwide from 2000 to 2019

Noncommunicable diseases now make up 7 of the world's top 10 causes of death, according to WHO's 2019 Global Health Estimates, published today.

9 Dec 2020

Researchers examine effectiveness of treating acute infectious diarrhea with probiotics

There is no evidence that probiotics are effective in treating acute infectious diarrhoea, state the authors of this Cochrane review update. Previous editions of the review had suggested they were; but a review update of the evidence, which included new trials, has overturned the review's previous findings.

9 Dec 2020

$Using fractional exponents in epidemic models could improve predictions of disease spread$

Using fractional exponents in epidemic models could improve predictions of disease spread

A new class of epidemiological models based on alternative thinking about how contagions propagate, particularly in the early phases of a pandemic, provide a blueprint for more accurate epidemic modeling and improved disease spread predictions and responses, according to a study published recently in Scientific Reports by researchers at the University of California, Irvine and other institutions.

8 Dec 2020

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Despite the encouraging news of potentially successful COVID-19 vaccine trials, there is not yet an FDA-approved vaccine available. Research into other effective coronavirus vaccines continues, including at UC Davis Health.

8 Dec 2020

GlycoNet scientists secure up to $4 million US investment to advance regenerative medicine

GlycoNet scientists Drs. Robert Ben and Jason Acker, who are revolutionizing the cryopreservation of cells, tissues and organs for human and veterinary therapies, have secured a $2-million USD equity investment for PanTHERA CryoSolutions (PanTHERA), a Canadian biotechnology start-up that they co-founded.

8 Dec 2020

Researchers develop new method to evaluate vaccine safety

A research group at the University of Turku, Finland, has led the development of a new method to evaluate vaccine safety. The new method may significantly reduce the use of animal testing in the vaccine industry.

8 Dec 2020

Possible new antibiotic developed for drug-resistant pulmonary pathogen

Scientists from Johns Hopkins University and Medicine have developed a possible new antibiotic for a pathogen that is notoriously resistant to medications and frequently lethal for people with cystic fibrosis and other lung ailments.

8 Dec 2020

Bioactive tea compounds show potential anti-SARS-CoV-2 activity

Scientists have revealed that certain bioactive compounds found in green, black, and oolong tea possess remarkable antiviral activities against SARS-CoV-2.

8 Dec 2020

Researchers address variability of disease severity in respiratory tract infections

Is it possible to predict the course of a viral respiratory tract infection - for instance one caused by a coronavirus - based on individual patient characteristics? This question will be addressed by Dr. Victor Corman and his junior research group at Charité - Universitätsmedizin Berlin.

8 Dec 2020

Researchers develop new approach for COVID-19 testing

Researchers from UC San Francisco and the Chan Zuckerberg Biohub have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected individuals.

7 Dec 2020

Global analysis tracks the impact of climate change on human health

Unless we take urgent action to tackle climate change, we can expect an ever-hotter world that threatens global health, disrupts lives and livelihoods and overwhelms healthcare systems, according to The Lancet's Global Countdown on Health and Climate Change, a comprehensive global analysis tracking the impact of climate change on human health across 41 key indicators.

7 Dec 2020

COVID-19 pandemic has led to a decrease in hospital-wide HCV testing

New research from Boston Medical Center finds that the COVID-19 emergency systemic changes made to decrease in-person visits during the pandemic have led to a decrease in hospital-wide Hepatitis C (HCV) testing by 50 percent, and a reduction in new HCV diagnoses by more than 60 percent.

4 Dec 2020

COVID-19 herd immunity threshold far higher than previously thought, say researchers

Researchers in the US have re-analyzed the data on herd immunity from spring 2020 from Europe. Their study shows that the herd immunity threshold is much higher than earlier speculated.

4 Dec 2020

Most countries are not fulfilling international legal obligations during COVID-19, study reveals

Most countries are not fulfilling their international legal obligations during COVID-19 and other public health emergencies, reveals new research by a consortium of 13 leading global health law scholars, hosted by the Global Strategy Lab (GSL) at York University.

4 Dec 2020

International scientific team reports 'super-spreader' potential of Andes virus

"Super-spreader" events and extensive person-to-person contact propelled an outbreak of hantavirus pulmonary syndrome in a small village in Argentina from 2018-2019, according to research published today in The New England Journal of Medicine.

3 Dec 2020

Genetically engineered T cells can target, attack pathogenic T cells that cause Type 1 diabetes

A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.

3 Dec 2020

New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours

Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.

3 Dec 2020

Feds look to pharmacists to boost childhood immunization rates

Torey Watson is trained as a pharmacist but aims to do more than simply fill prescriptions.

3 Dec 2020

Infectious Diseases News and Research

UofL receives DoD funding to develop a nasal spray for preventing COVID-19

Neutrophils may play a key role in COVID-19-related thrombosis

WHO highlights leading causes of mortality and morbidity worldwide from 2000 to 2019

Researchers examine effectiveness of treating acute infectious diarrhea with probiotics

Using fractional exponents in epidemic models could improve predictions of disease spread

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

GlycoNet scientists secure up to $4 million US investment to advance regenerative medicine

Researchers develop new method to evaluate vaccine safety

Possible new antibiotic developed for drug-resistant pulmonary pathogen

Bioactive tea compounds show potential anti-SARS-CoV-2 activity

Researchers address variability of disease severity in respiratory tract infections

Researchers develop new approach for COVID-19 testing

Global analysis tracks the impact of climate change on human health

COVID-19 pandemic has led to a decrease in hospital-wide HCV testing

COVID-19 herd immunity threshold far higher than previously thought, say researchers

Most countries are not fulfilling international legal obligations during COVID-19, study reveals

International scientific team reports 'super-spreader' potential of Andes virus

Genetically engineered T cells can target, attack pathogenic T cells that cause Type 1 diabetes

New antiviral drug completely suppresses SARS-CoV-2 transmission within 24 hours

Feds look to pharmacists to boost childhood immunization rates

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News